Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ARENA PHARMACEUTICALS INC | Financial_Report.xls |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - ARENA PHARMACEUTICALS INC | d268596dex211.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ARENA PHARMACEUTICALS INC | d268596dex311.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ARENA PHARMACEUTICALS INC | d268596dex231.htm |
| EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - ARENA PHARMACEUTICALS INC | d268596dex321.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - ARENA PHARMACEUTICALS INC | d268596dex312.htm |
| EX-3.8 - CERTIFICATE OF DESIGNATIONS - ARENA PHARMACEUTICALS INC | d268596dex38.htm |
| 10-K - FORM 10-K - ARENA PHARMACEUTICALS INC | d268596d10k.htm |
| EX-10.36 - AMENDMENT NO.5 TO THE TOLL MANUFACTURING AGREEMENT - ARENA PHARMACEUTICALS INC | d268596dex1036.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-45330, 333-45332, 333-62894, 333-86350, 333-135398 and 333-160329) and Form S-3 (Nos. 333-177826, 333-112542, 333-136023, 333-160983, 333-166481 and 333-167498) of Arena Pharmaceuticals, Inc. and in the related Prospectuses of our report dated March 16, 2010, with respect the consolidated financial statements of Arena Pharmaceuticals, Inc. included in the Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP
San Diego, California
March 15, 2012